fund
Marlborough UK Multi-Cap Growth A
Multicap UK equity fund aiming for capital growth.
-
207.54p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
-
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
5.00% 0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
1.50%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
1.57%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
0.50%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
Fund summary
Sector | UK All Companies |
Structure | UNIT TRUST |
Launched | July, 1995 |
Size | £100m |
Yield | 0.50% |
Charging basis | Income |
Dividends paid | 20/05 20/11 |
Charges
Standard initial charge | 5.00% |
Initial charge via Bestinvest | 0.00% |
Additional bid/offer spread | 0.00% |
Annual management charge | 1.50% |
Ongoing charges figure | 1.57% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
Manager research
Average monthly relative returns
- 14/15 1.47%
- 15/16 0.08%
- 16/17 0.83%
- 17/18 0.56%
- 18/19 -0.65%
Bestinvest MRI
- 3 years 0.24%
- 5 years 0.46%
- Career 0.36%
- 3 years 73.60%
- 5 years 93.20%
- Career 91.30%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Richard Hallett
Hallett qualified as a Chartered Accountant at Ernst & Young in 1994 and subsequently joined Singer & Friedlander in 1995 as a UK Equity fund manager.
Track record
Richard Hallett has 6.3 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.36%. During the worst period of relative performance (from August 2018 - December 2018) there was a decline of 14% relative to the index. The worst absolute loss has been 23%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 91%.
Periods of worst performance
Absolute | -23.00% (August 2018 - December 2018) |
Relative | -14.00% (August 2018 - December 2018) |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Top 10 holdings
Data accurate as at 30 August 2019
4.4474% | London Stock Exchange Group |
4.1055% | Homeserve |
3.9002% | Fidelity National Info Services Inc |
3.8967% | Rentokil Initial |
3.8625% | Smith & Nephew |
3.8096% | Jd Sports Fashion Plc |
3.7758% | Experian Plc |
3.6442% | Astrazeneca Plc |
3.5272% | Tesco |
3.5161% | Dechra Pharmaceuticals |
Source: Trustnet |
Sector breakdown
Industrials | 29.00% |
Financials | 21.00% |
Health Care | 17.00% |
Technology | 11.00% |
Consumer Discretionary | 9.00% |
Consumer Staples | 7.00% |
Cash & Cash Equivalents | 3.00% |
Telecommunications | 2.00% |
Basic Materials | 1.00% |
Key Investor Information